SARS-CoV-2 and the safety margins of cell-based biological medicinal products

With the pandemic emergence of SARS-CoV-2, the exposure of cell substrates used for manufacturing of medicines has become a possibility. Cell lines used in biomanufacturing were thus evaluated for their SARS-CoV-2 susceptibility, and the detection of SARS-CoV-2 in culture supernatants by routine adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Modrof, Jens, Kerschbaum, Astrid, Farcet, Maria R., Niemeyer, Daniela, Corman, Victor M., Kreil, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456270/
https://www.ncbi.nlm.nih.gov/pubmed/32891497
http://dx.doi.org/10.1016/j.biologicals.2020.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456270/
https://www.ncbi.nlm.nih.gov/pubmed/32891497
http://dx.doi.org/10.1016/j.biologicals.2020.08.010

Ejemplares similares